• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » Smith & Nephew CEO Illingsworth announces retirement on earnings call

Smith & Nephew CEO Illingsworth announces retirement on earnings call

February 10, 2011 By MassDevice staff

SNN logo

David Illingsworth is leaving the corner office at Smith & Nephew plc (NYSE:SNN), the company announced today as part of its fourth-quarter earnings release.

Illingsworth, who is retiring after a nine-year tenure at the helm of the British orthopedics giant, will be replaced by Olivier Bohuon, whom the company poached from French pharmaceuticals firm Pierre Fabre. Bouhon also ran the pharmaceutical business of Abbott Laboratories. The transition, which has been in the works for months, is set to take place April 14.

“The board is very sorry to see Dave go,” Smith & Nephew chairman John Buchanan said during a presentation with investors. “Dave’s nine years have been characterized by a customer-oriented approach aimed at creating shareholder value.”

Illingsworth made what will be his last annual earnings call with investors today, saying the company posted $3.96 billion in total sales for 2010, up 4 percent from $3.77 billion in 2009. The uptick was driven by increases of 7 percent increase each for SNN’s wound management and endoscopy businesses.

The company’s bread and butter orthopedics business was up about 2 percent, to $2.19 billion. Overall, the company reported profits of $615 million profit, up 30 percent from $472 million in 2009.

For the three months ended Dec. 31, Smith & Nephew reported profits of $182 million on $1.06 billion in sales, a bottom-line increase of 42 percent compared with $128 million profit the company posted on $1.06 billion in sales during the same period in 2009.

“The market conditions were what we expected,” Illingsworth said. “I believe we have managed pretty well in this environment.”

The earnings release pushed shares of SNN up 2.4 percent to $58.80 in mid-day trading. Smith & Nephew’s stock has been up about 14 percent over the past month on rumors of a possible sale to Johnson & Johnson, which first surfaced in January.

The company has said it is not for sale, despite the persistent speculation.

Filed Under: MassDevice Earnings Roundup, News Well, Orthopedics Tagged With: Q4, Smith & Nephew

More recent news

  • Johnson & Johnson MedTech launches new Volt plating systems for radius, humerus
  • PharmaSens, SiBionics collab on all-in-one insulin patch pump
  • Beta Bionics to pair iLet automated insulin delivery system with Abbott’s dual glucose-ketone sensor
  • Anaconda Biomed wins CE mark for funnel catheter
  • FDA approves Neuspera neuromod for urinary incontinence

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy